The National Law Review is pleased to inform you of IQPC’s e-Discovery for Pharma, Biotech & Medial Device Industries Conference in Philadelphia on October 24-25, 2011. We’ve provided some information on the conference for your convenience:
Mastering eDiscovery and Information management strategies and best practices fit for life sciences industries
Why attend eDiscovery for Pharma?
- Learn from industry leaders who have successfully implemented technology solutions that have reduced cost and errors in eDiscovery production. Network with government and industry leaders who are influencing the practice and procedure of eDiscovery in the Pharmaceutical, Biotech and Medical Device Industries.
- Prepare your organization with defensible information management techniques specifically geared toward global pharmaceutical data.
- Join peer discussions on industry hot topics such as predictive coding, cloud computing and legal holds.
- Avoid mistakes and costly sanctions for eDiscovery misconduct and Federal Corrupt Practices Act investigations.
- Benchmark your internal processes and evaluate their effectiveness in practical scenarios.
Hear Perspectives from:
- Edward Gramling, Senior Corporate Counsel at Pfizer
- John O’Tuel, Assistant General Counsel at GlaxoSmithKline
- Chris Garber, eDiscovery Manager atAllergan, Inc
- HB Gordon, eDiscovery Analyst, Legal Affairs, Teva Pharmaceuticals USA
- David Kessler, Partner at Fulbright & Jaworski
- Phil Yannella, Partner at Ballard & Spahr
